FDA User Fees Should Be On Chopping Block – Legal Luminary Hutt
This article was originally published in The Gray Sheet
Executive Summary
FDA user fees are destructive to the agency's mission and should be discontinued, says Washington attorney and FDA expert Peter Barton Hutt
You may also be interested in...
FDA Scientific Capacity Inadequate; New Device Technology At Risk
CDRH is not equipped to understand the science behind many cutting-edge device technologies, says a Nov. 29 report from the Subcommittee on Science and Technology, an ad hoc panel of the FDA Science Board
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.